PTEN, a tumor suppressor gene controlling the PI3K/AKT pathway by phosphorylating PIP3 at the cell membrane, is the most common genetic alteration (30–80%) in endometrial carcinomas. This evidence concerns the gene PTEN and endometrial carcinoma.